Chih Hung Yeh

Chih Hung Yeh is currently the General Manager & Director at Taiwan Liposome Co., Ltd., the Director at TLC Biopharmaceuticals HK Ltd., the Managing Director at TLC Biopharmaceuticals B.V., the General Manager & Director at TLC Biopharmaceuticals Shanghai Ltd., the Director at TLC Biopharmaceuticals Pty Ltd., the President & Director at TLC Biopharmaceuticals Japan Co., Ltd., the Director at Steminent Biotherapeutics, Inc., the Director at Woods Investment Co. Ltd., and the General Manager at TLC Biopharmaceuticals, Inc. .
Mr. Yeh previously worked as an Associate at General Bank, the Chief Financial Officer at Hermes Biosciences, Inc., and the Vice President at Asiawired Group.
Mr. Yeh received an undergraduate degree from the University of California, Berkeley, and graduate degrees including an MBA from the University of Michigan.